sulfathiazole has been researched along with Hepatitis B in 1 studies
Sulfathiazole: A sulfathiazole compound that is used as a short-acting anti-infective agent. It is no longer commonly used systemically due to its toxicity, but may still be applied topically in combination with other drugs for the treatment of vaginal and skin infections, and is still used in veterinary medicine.
sulfathiazole : A 1,3-thiazole compound having a 4-aminobenzenesulfonamido group at the 2-position.
Hepatitis B: INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Usmanova, LP | 1 |
| Kasimova, NB | 1 |
| Kuznetsova, TA | 1 |
| Kotel'nikova, LI | 1 |
| Bogdanova, AG | 1 |
| Cherenova, OP | 1 |
1 other study available for sulfathiazole and Hepatitis B
| Article | Year |
|---|---|
[The effect of the acetylation phenotype on the course severity and outcome of acute viral hepatitis B].
Topics: Acetylation; Acute Disease; Adolescent; Adult; Hepatitis B; Hepatitis B Surface Antigens; Humans; Mi | 1996 |